TransGenRx
TransGenRx, a biopharmaceutical manufacturing company, has developed technology that significantly reduces the cost of producing protein-based drugs by using a high-expressing avian cell line combined with their patented vector system. Patented and patent pending processes allow TGRx to develop custom proteins to meet a wide range of specifications. Dr. Richard Cooper, a professor in the AgCenter Department of Veterinary Science, serves as the company's Executive Vice President of Research and Development. Since its inception, the company has won an STTR phase II award and has won contracts with drug manufacturers for its proteins and hormones.
June 06, 2003
LSU AgCenter Announces Biotechnology Breakthrough
August 2005
TGRx Wins 2005 ‘Quality Award’ from U.S. Army
October 29, 2009
TransGenRx wins hormone contract
To find more information about TransGenRx, visit: http://www.tgrxinc.com/
|